The enigma of mixed dementia
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Mixed type dementia (MD) refers to a combination of Alzheimer disease (AD) and vascular encephalopathy (VE) and other dementia disorders, but the distinction between these diseases is difficult. For the diagnosis of MD, the clinical/neuroimaging criteria of probable AD plus vascular cognitive impairment (VCI) as separate entities are used. Both disorders increase exponentially with age, but their interactions are common and controversial. Pathologic diagnosis is based on the combination of autopsy‐proven AD with multiple vascular or ischemic brain lesions. The population‐based incidence and prevalence of MD is unknown. In retrospective and prospective autopsy studies, its prevalence ranges from 2% to 58% with reasonable means of 6% to 12%, although findings from several recent studies indicated frequent coexistence of AD with multiple cerebrovascular lesions (CVLs) in cognitively impaired elderly subjects. In both AD and VCI, vascular lesions frequently involve subcortical regions (basal ganglia, thalamus, hippocampus, white matter) or are multiple microinfarcts, whereas in MD large/hemispheral infarcts and multiple microinfarcts are more frequent, suggesting different pathogenic mechanisms. There is increasing evidence that critically located small CVLs can induce/promote cognitive impairment in early‐stage AD but not once AD pathology becomes more advanced. Discussion of the major pathogenic factors inducing AD, VCI, and MD suggests synergistic relations between these disorders. Currently available clinical and morphologic criteria for AD and VCI are of limited value for the diagnosis of MD, and the ability of current consensus criteria to distinguish between AD, VCI, and MD is limited. Therefore, future development of methods that more accurately characterize the impact of both AD‐related and vascular brain injuries are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 2×
“Microvascular changes in the aged brain and in AD include mpaired cerebral perfusion, in particular, decrease of regional lood flow, a reduction of glucose transport and utilization, a oss of vascular innervation with special impact on the cholinrgic and other neurotransmitter deficits in AD, impairment of eurogenic c…”
BackgroundThe Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · cited 1×
“Microvascular changes in the aged brain and in AD include mpaired cerebral perfusion, in particular, decrease of regional lood flow, a reduction of glucose transport and utilization, a oss of vascular innervation with special impact on the cholinrgic and other neurotransmitter deficits in AD, impairment of eurogenic c…”
BackgroundSelf-citationBerg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., & Nieuwstraten, P. (1988) · Neurology · doi:10.1212/wnl.38.3.359 · Cited by 613
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530
Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease
Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250089017 · Cited by 514 · cited 1×
“[76] Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, et al.”
BackgroundCerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., & Smith, A. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02355-7 · Cited by 493
Petrovitch, H., White, L. R., Izmirilian, G., Ross, G. W., Havlik, R. J., Markesbery, W., Nelson, J., Davis, D. G., Hardman, J., Foley, D. J., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00106-8 · Cited by 468
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
Schneider, J. A., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000118211.78503.f5 · Cited by 436
Schmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M., & Fazekas, F. (2005) · Annals of Neurology · doi:10.1002/ana.20630 · Cited by 408
Risk Factors for Vascular Dementia and Alzheimer Disease
Gorelick, P. B. (2004) · Stroke · doi:10.1161/01.str.0000143318.70292.47 · Cited by 365
Clearing amyloid through the blood-brain barrier
Zlokovic, B. V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02385.x · Cited by 336
Pohjasvaara, T., Erkinjuntti, T., Vataja, R., & Kaste, M. (1997) · Stroke · doi:10.1161/01.str.28.4.785 · Cited by 328
HULETTE, C. M., WELSH-BOHMER, K. A., MURRAY, M. G., SAUNDERS, A. M., MASH, D. C., & MCINTYRE, L. M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00009 · Cited by 311
Relation of cerebral infarctions to dementia and cognitive function in older persons
Schneider, J. A., Wilson, R. S., Cochran, E. J., Bienias, J. L., Arnold, S. E., Evans, D. A., & Bennett, D. A. (2003) · Neurology · doi:10.1212/01.wnl.0000055863.87435.b2 · Cited by 305
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291
Atherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center
Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284
Berg, L., McKeel, D. W., Miller, J. P., Baty, J., & Morris, J. C. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040011008 · Cited by 257 · cited 1×
“[63] Berg L, McKeel DW, Miller JP, Baty J, Morris JC.”
BackgroundSporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 242
Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia
Zarow, C., Vinters, H. V., Ellis, W. G., Weiner, M. W., Mungas, D., White, L., & Chui, H. C. (2005) · Annals of Neurology · doi:10.1002/ana.20503 · Cited by 241
Vascular pathologies and cognition in a population-based cohort of elderly people
Fernando, M. S., & Ince, P. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.004 · Cited by 239 · cited 12×
“VaD/VCI [2,5] includes a heterogeneous group of cogitive disorders caused by or related to various types of erebrovascular lesions (CVL) and ischemic brain damage, ummarized in Table 1.”
BackgroundInfluentialAD lesions and infarcts in demented and non‐demented Japanese‐American men
Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., Nelson, J., Hardman, J., Masaki, K., Vogt, M. R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20318 · Cited by 230
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
Bailey, T. L., Rivara, C. B., Rocher, A. B., & Hof, P. R. (2004) · Neurological Research · doi:10.1179/016164104225016272 · Cited by 213 · cited 3×
“[20] Bailey TL, Rivara CB, Rocher AB, Hof PR.”
BackgroundCortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Michel, J.-P., Bouras, C., & Giannakopoulos, P. (2004) · Stroke · doi:10.1161/01.str.0000110791.51378.4e · Cited by 202
White, L., Small, B. J., Petrovitch, H., Ross, G. W., Masaki, K., Abbott, R. D., Hardman, J., Davis, D., Nelson, J., & Markesbery, W. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281872 · Cited by 155 · cited 2×
“Although 16% were ttributed to mixed cases during life, almost 40% were found o have significant mixtures of dementia-related lesions at utopsy [53].”
BackgroundDecline in intelligence is associated with progression in white matter hyperintensity volume
Garde, E. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055905 · Cited by 118
Alafuzoff, I., Pikkarainen, M., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Ferrer, I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229986.17548.27 · Cited by 117
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study
Lopez, O. L., Kuller, L. H., Becker, J. T., Jagust, W. J., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Kawas, C., & Carlson, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159860.19413.c4 · Cited by 109 · cited 2×
“The urrently used criteria for the clinical diagnosis of AD CERAD, NINDS-Alzheimer’s Disease and Related Disorers Association criteria [26,48]) and for VaD (see [5]) are f limited value for the diagnosis of MD, and the diagnostic ate, when applied to the same group of demented patients, etween the published diagnostic…”
BackgroundMethodNeurovascular Pathways and Alzheimer Amyloid β-peptide
Zlokovic, B. V., Deane, R., Sallstrom, J., Chow, N., & Miano, J. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00103.x · Cited by 104
Neuropathology of mild cognitive impairment
Saito, Y., & Murayama, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00806.x · Cited by 92
McKeel, D. W., Price, J. L., Miller, J. P., Grant, E. A., Xiong, C., Berg, L., & Morris, J. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1028 · Cited by 68 · cited 1×
“[65] McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L, et al.”
BackgroundVascular cognitive impairment: Today and tomorrow
Chui, H. C. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2006.03.003 · Cited by 44
Jellinger, K. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.520 · Cited by 37
Self-citation
Research works printed but not linked: 114
- Erkinjuntti T, 2004, Stroke: pathophysiology, diagnosis, and management, 648, 10.1016/B0-44-306600-0/50035-3 · DOI
- Bowler JV, 2003, Vascular cognitive impairment: preventable dementia, 1, 10.1093/oso/9780192632678.001.0001 · DOI
- Merino JG, 2005, Vascular dementia: cerebrovascular mechanisms and clinical management, 57, 10.1385/1-59259-824-2:057 · DOI
- 10.1016/j.jns.2004.11.016 · DOI
- 10.3109/9781420016819-12 · DOI
- Jellinger KA, 2004, Current clinical neurology: Vascular dementia: cerebrovascular mechanisms and clinical management, 23
- 10.1179/016164104225016254 · DOI · Paper page
- 10.1016/S1474-4422(04)00683-0 · DOI · Paper page
- 10.1097/00002093-199912003-00016 · DOI · Paper page
- 10.1179/016164104225017668 · DOI · Paper page
- 10.1016/j.jns.2004.11.018 · DOI
- 10.1111/j.1600-0404.2006.00665.x · DOI · Paper page
- 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page
- Vinters HV, 2003, Amyloidosis of cerebral arteries, Adv Neurol., 92, 105
- 10.1159/000079192 · DOI · Paper page
- 10.1097/01.wad.0000167923.56275.d8 · DOI · Paper page
- 10.1016/j.tins.2005.02.001 · DOI · Paper page
- 10.1161/01.STR.0000014421.15948.67 · DOI · Paper page
- 10.1212/01.wnl.0000168863.49053.4d · DOI · Paper page
- 10.1212/WNL.45.3.461 · DOI · Paper page
- Lewis H, 2006, Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia, Neuropathol Appl Neurobiol., 32, 103, 10.1111/j.1365-2990.2006.00696.x · DOI · Paper page
- 10.1111/j.1750-3639.2006.tb00560.x · DOI · Paper page
- Weller RO, 2004, Cerebrovascular disease and the pathophysiology of Alzheimer's disease: Implications for therapy, Panminerva Med., 47, 239
- 10.1159/000106940 · DOI · Paper page
- Crystal H, 2002, Cerebral infarcts in patients with autopsy proven Alzheimer's disease [abstr], Neurobiol Aging., 23, 207
- Duyckaerts C, 2003, Neurodegeneration: The molecular pathology of dementia and movement disorders, 47
- 10.1097/00019442-199700540-00002 · DOI
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- World Health Organization, 1993, International classification of diseases
- 10.1136/jnnp.53.11.961 · DOI · Paper page
- Erkinjuntti T, 2000, Research criteria for subcortical vascular dementia in clinical trials, J Neural Transm (Suppl)., 59, 23
- Bowler JV, 2003, Vascular cognitive impairment
- 10.1016/j.jalz.2006.04.002 · DOI
- Jellinger KA, 2004, Pathology and pathophysiology of vascular cognitive impairment: A critical update, Panminerva Med., 46, 217
- Jellinger KA, 2005, Understanding the pathology of vascular cognitive impairment, J Neurol Sci., 229, 57, 10.1016/j.jns.2004.11.029 · DOI
- 10.1212/WNL.34.7.939 · DOI · Paper page
- 10.1159/000094973 · DOI · Paper page
- 10.1176/appi.ajp.159.1.82 · DOI · Paper page
- JPBacchetta EKovari MMerlo ACanuto FRHerrmann CBouras et al.Validation of clinical criteria for possible vascular dementia in the oldest-old. Neurobiol Aging2006 Mar 29; [Epub ahead of print]: DOI10.1016/j.neurobiolaging.2006.006. · doi:10.1016/j.neurobiolaging.2006.006
- 10.3233/JAD-2006-9S308 · DOI · Paper page
- 10.1001/archneur.1987.00520130016010 · DOI · Paper page
- Winblad B, 1986, Dimensions in aging, 183
- Knopman DS, 2003, Neurodegeneration: The molecular pathology of dementia and movement disorders, 24
- 10.1001/archneur.1985.04060100083029 · DOI · Paper page
- 10.1097/00005072-198705000-00003 · DOI · Paper page
- 10.1212/01.WNL.0000118212.41542.E7 · DOI · Paper page
- Jellinger KA, 2003, Neurodegeneration: the molecular pathology of dementia and movement disorders, 66
- KAJellinger JAttems.Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol2006 Nov 7; [Epub ahead of print]: DOI10.1007/s00401-006-0156-7. · DOI
- Mirra SS, 2002, Greenfield's neuropathology, 195
- 10.1097/00002093-199809000-00010 · DOI · Paper page
- 10.1212/WNL.42.2.329 · DOI · Paper page
- 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- 10.1097/00005072-199107000-00008 · DOI · Paper page
- 10.1212/WNL.52.6.1158 · DOI · Paper page
- 10.1161/01.STR.0000166052.89772.b5 · DOI · Paper page
- Zekry D, 2005, [Mixed dementia: a neuropathologic point of view], Psychol Neuropsychiatr Vieil., 3, 251
- 10.1016/S0165-0173(97)00023-4 · DOI · Paper page
- 10.1097/00005072-199702000-00007 · DOI · Paper page
- Woodward M, 2006, High prevalence of multiple brain pathologies in dementia, Alzheimer's & Dementia., 2, S426
- Lobo A, 2000, Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts: Neurologic Diseases in the Elderly Research Group, Neurology., 54, S4
- 10.1111/j.1532-5415.2004.52058.x · DOI · Paper page
- 10.1212/01.WNL.0000160107.02316.BF · DOI · Paper page
- 10.1001/archneur.59.10.1605 · DOI · Paper page
- 10.1111/j.1532-5415.1998.tb01076.x · DOI · Paper page
- 10.1016/0022-510X(75)90116-1 · DOI
- 10.1136/jnnp.48.11.1085 · DOI · Paper page
- 10.1007/BF00313858 · DOI
- 10.1007/BF00688184 · DOI · Paper page
- 10.1002/ana.410240110 · DOI · Paper page
- 10.1002/ana.410240306 · DOI · Paper page
- 10.1212/WNL.39.1.76 · DOI · Paper page
- O'Brien MD, 1994, How does cerebrovascular disease cause dementia?, Dementia, 5, 133
- 10.1016/0022-510X(90)90072-U · DOI · Paper page
- 10.1159/000106712 · DOI · Paper page
- Markesbery WR, 1998, Neuropathology of dementing disorders, 293
- 10.1002/ana.10161 · DOI · Paper page
- 10.1111/j.1532-5415.1999.tb02571.x · DOI · Paper page
- 10.1001/archneur.61.10.1545 · DOI · Paper page
- 10.1159/000083801 · DOI · Paper page
- 10.1007/s00415-003-0142-0 · DOI
- 10.1161/01.STR.0000024523.82311.77 · DOI · Paper page
- 10.1001/archneur.1994.00540220045013 · DOI · Paper page
- 10.1007/s00401-003-0738-6 · DOI · Paper page
- 10.1007/s00401-003-0738-6 · DOI · Paper page
- 10.1001/archneur.57.10.1474 · DOI · Paper page
- 10.1016/j.jns.2004.08.016 · DOI
- 10.1007/s00415-002-0883-1 · DOI
- 10.1111/j.1749-6632.2000.tb06347.x · DOI · Paper page
- 10.3233/JAD-1998-1205 · DOI · Paper page
- 10.1023/B:NERE.0000023612.66691.e6 · DOI
- 10.1016/0022-510X(96)00008-1 · DOI
- Jellinger KA, 2005, Current clinical neurology: Vascular dementia: cerebrovascular mechanisms and clinical management, 23
- Frisoni GB, 2001, Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease, Arch Neurol., 58, 1939, 10.1001/archneur.58.11.1939 · DOI
- 10.1016/S0022-510X(02)00282-4 · DOI
- Jellinger KA, 2002, Vascular-ischemic dementia: an update, J Neural Transm., 62, 1
- 10.1179/016164104225014003 · DOI · Paper page
- 10.1007/s00401-006-0054-z · DOI
- Thomas A, 2005, Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia, Dement Geriatr Cogn Disord., 19, 57, 10.1159/000082349 · DOI
- 10.1111/j.1749-6632.1997.tb48511.x · DOI
- 10.1001/archneur.1995.00540310076019 · DOI · Paper page
- 10.1002/ana.410010621 · doi:10.1002/ana.410010621
- Tian J, 2004, Cerebral amyloid angiopathy and dementia, Panminerva Med., 46, 253
- 10.1212/01.wnl.0000223613.57229.24 · DOI · Paper page
- 10.1159/000092958 · DOI · Paper page
- 10.1002/gps.1550 · DOI · Paper page
- 10.1016/j.brainresrev.2004.12.014 · DOI
- 10.1136/jnnp.2003.023713 · DOI · Paper page
- 10.1016/j.neurobiolaging.2004.05.002 · DOI
- 10.1161/01.STR.0000133686.29320.58 · DOI · Paper page
- 10.1136/jnnp.2005.064998 · DOI · Paper page
- 10.1136/jnnp.2003.019273 · DOI · Paper page
- 10.1136/jnnp.2005.070193 · DOI · Paper page
- 10.1016/j.jns.2004.09.016 · DOI · Paper page
- 10.4065/81.2.223 · DOI
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Metadata
- Authors
- Jellinger, K. A.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 3
- Issue
- 1
- Pages
- 40-53
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2076929722
- Cited by
- 138
- References
- 49
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.